ArticleMolecular biology reports2025
A retrospective Case-Control study investigating the association of XPC Lys939Gln (rs2228001), XPD Lys751Gln (rs13181), and TP53 Arg72Pro (rs1042522) with papillary thyroid carcinoma susceptibility in the Bangladeshi population.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPapillary thyroid carcinoma (PTC) is the most common thyroid malignancy, particularly among females. Polymorphisms in DNA repair and tumor suppressor genes such as XPC, XPD, and TP53 may influence cancer susceptibility. This study investigated the association of XPC Lys939Gln, XPD Lys751Gln, and TP53 Arg72Pro variants and PTC risk in a Bangladeshi population, supported by in-silico analyses.
methodsA retrospective case-control study was conducted involving 166 PTC patients and 180 controls. Genotyping was performed using PCR-RFLP and allele-specific multiplex PCR. Logistic regression assessed associations, with subgroup analyses stratified by gender, smoking, and family history. Functional, structural, RNA, splicing, and regulatory effects of each variant were predicted using multiple bioinformatics tools. Pearson's correlation evaluated genotype co-occurrence.
resultsMutant genotypes of all three genes were significantly more frequent in cases. XPD Gln/Gln and TP53 Arg/Pro variants conferred the highest risk. Associations were stronger in females, non-smokers, and individuals with a family history of cancer. Combined genotype analysis suggested synergistic effects. In silico predictions flagged TP53 as most functionally impactful. Structural modeling revealed minimal protein-level disruptions; however, mRNA-level analysis showed reduced transcript stability and increased conformational variability for XPD and TP53. Splicing predicted altered motifs and cryptic site activation for XPD. RegulomeDB suggested strong regulatory potential for XPC. Pearson's correlation revealed mutual exclusivity between XPC and XPD in cases.
conclusionXPC, XPD, and TP53 variants are significantly associated with PTC risk in Bangladeshi population. Combined genetic and bioinformatics evidence supports their potential as biomarkers for risk stratification, warranting larger functional studies.
Indexed as
Identifiers
41307639What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.